Our library of clinical trials information is updated regularly from the US government database on clinical trials, so you can be assured that new aciphex clinical trials listings will be included here shortly after becoming available to us.
Related Sponsors
Clinical Trials on aciphex
- E3810-A001-313: Efficacy and Safety of 10 mg Rabeprazole for Treating Heartburn in Frequent Sufferers
Status: Completed, Condition Summary: Heartburn - E3810-A001-312: Efficacy and Safety of 10 mg Rabeprazole for Treating Heartburn in Frequent Sufferers
Status: Completed, Condition Summary: Heartburn - Treatment of Gastroesophageal Reflux Disease in 12-16 Year Old Patients With Rabeprazole
Status: Completed, Condition Summary: Gastroesophageal Reflux Disease GERD - Prospective Double-Blinded Randomized Controlled Trial of 12-Weeks High Dose Rabeprazole (Pariet) in the Treatment of Reflux Laryngitis in Chinese Patients
Status: Recruiting, Condition Summary: Gastroesophageal Reflux; Laryngitis - Open Label Study Evaluating Different Dosing Regimens of Rabeprazole in Gastro-Esophageal Reflux Disease (GERD) Patients With Night-Time Heartburn Symptoms.
Status: Completed, Condition Summary: Gastroesophageal Reflux; Heartburn - A Study of the Use of High-Dose Proton Pump Inhibitor for the Treatment of Gastro-Oesophageal Reflux Related Non-Cardiac Chest Pain - a Randomized Double-Blind Placebo-Controlled Study
Status: Recruiting, Condition Summary: Chest Pain - A Study to Compare the Number of Patients With Gastro-Oesophageal Reflux Disease (GORD) Achieving Heartburn and Regurgitation Symptom Resolution After Treatment With Either Rabeprazole Sodium 20mg, Esomeprazole 20mg or Esomeperazole 40m
Status: Recruiting, Condition Summary: Gastro-Oesophageal Reflux - Study of Changes in Reflux Symptoms and Reflux Finding Score According to Rabeprazole Treatment Period.
Status: Not yet recruiting, Condition Summary: Gastroesophageal Reflux; Pharyngeal Disease - A Comparative Study of Proton-Pump Inhibitor Tests for Chinese Reflux Patients in Relation to the CYP2C19 Genotypes
Status: Completed, Condition Summary: GERD - Rabeprazole Extended-Release, 50 mg, Versus Esomeprazole, 40 mg, for Healing and Symptomatic Relief of Moderate to Severe Erosive Gastroesophageal Reflux Disease (GERD)
Status: Recruiting, Condition Summary: Gastroesophageal Reflux Disease (GERD) - Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Moderate to Severe Erosive Gastroesophageal Reflux Disease (GERD)
Status: Recruiting, Condition Summary: Gastroesophageal Reflux Disease (GERD) - Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Mild to Moderate Erosive Gastroesophageal Reflux Disease (GERD)
Status: Recruiting, Condition Summary: Gastroesophageal Reflux Disease (GERD) - Fasting Study of Rabeprazole Sodium Delayed-Release Tablets 20 mg to Aciphex® Delayed-Release Tablets 20 mg
Status: Completed, Condition Summary: Healthy - Food Study of Rabeprazole Sodium Delayed-Release Tablets 20 mg to Aciphex® Tablets 20 mg
Status: Completed, Condition Summary: Healthy - Fed Study of Rabeprazole Sodium Tablets 20 mg and Aciphex® Tablets 20 mg
Status: Completed, Condition Summary: Healthy - A Study to Monitor Intragastric pH in Patients Taking Rabeprazole vs. Patients Taking Pantoprazole
Status: Completed, Condition Summary: GERD - Study of the Safety and Effectiveness of Rabeprazole in Treatment of Helicobacter Pylori Infection in Adults.
Status: Completed, Condition Summary: Bacterial Infections; Helicobacter Infections - A Study of the Safety of Rabeprazole Administered to Adults With Gastroesophageal Reflux Disease (GERD)
Status: Completed, Condition Summary: Heartburn; Gastroesophageal Reflux - Laryngopharyngeal Reflux and Proton Pump Inhibitor (PPI) Treatment
Status: Completed, Condition Summary: Laryngopharyngeal Reflux - Rabeprazole Protection of Aspirin Induced Gastric Damage.
Status: Completed, Condition Summary: Normal Subjects - Trial of Electrosurgical Incision Versus Bougie Dilation of Symptomatic Lower Esophageal (Schatzki's) Rings
Status: Completed, Condition Summary: Lower Esophageal Ring; Dysphagia - A Study of Rabeprazole and Pantoprazole on Stomach Acid and Esophageal Acid Exposure in Patients With Gastroesophageal Reflux Disease (GERD) and a History of Nighttime Heartburn
Status: Completed, Condition Summary: Gastroesophageal Reflux - The Proton Pump Inhibitor (PPI) Test for the Extraesophageal Manifestation of GERD
Status: Recruiting, Condition Summary: Gastroesophageal Reflux Disease - Compare How Effective Standard Dose Proton Pump Inhibitor (PPI) and Low Dose Tricyclic Antidepressant and Double Dose PPI to Standard Dose PPI and Placebo
Status: Recruiting, Condition Summary: Gastroesophageal Reflux Disease - Importance of Cytokines in Peptic Ulcer Disease: Implications for Treatment
Status: Recruiting, Condition Summary: Peptic Ulcer - Comparison of the Nighttime Effects of Two Different Drugs on Subjects With GERD
Status: Completed, Condition Summary: Gastroesophageal Reflux Disease - Safety of Rabeprazole in Patients Under Multiple Treatments.
Status: Active, not recruiting, Condition Summary: Gastric Ulcer; Gastroesophageal Reflux - Influence of Hygiene-Dietetic Habits and Treatment Adherence on the Effectiveness of the Gastroesophageal Reflux Illness Treatment With Rabeprazol.
Status: Active, not recruiting, Condition Summary: Gastroesophageal Reflux - Rabeprazole in Subjects With Gastroesophageal Reflux Disease (GERD)
Status: Completed, Condition Summary: Esophageal Reflux - A Comparative Study on the Efficacy and Safety of E3810 in Patients With Non-Erosive Gastroesophageal Reflux Disease
Status: Completed, Condition Summary: Non-Erosive Gastroesophageal Reflux Disease